Abiomed
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Abiomed's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $1,031,753,000. Profit margin reached 13%. Total operating expenses were $586,889,000.

Profit Margin

Abiomed, Inc. (NASDAQ:ABMD): Profit margin
2013 158.12M 15.01M 9.5%
2014 183.64M 7.35M 4%
2015 230.31M 113.68M 49.36%
2016 329.54M 38.14M 11.58%
2017 445.30M 52.11M 11.7%
2018 593.74M 112.17M 18.89%
2019 769.43M 259.01M 33.66%
2020 840.88M 203.00M 24.14%
2021 847.52M 225.52M 26.61%
2022 1.03B 136.50M 13.23%

ABMD Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
1.03B847.52M840.88M769.43M593.74M445.30M329.54M230.31M183.64M158.12M
Cost of revenue
188.15M161.90M151.30M129.56M98.58M70.62M50.41M39.94M37.32M31.59M
Gross profit
843.59M685.61M689.57M639.86M495.16M374.67M279.12M190.36M146.32M126.52M
Operating exp.
Research and development
163.40M121.87M98.75M93.50M75.29M66.38M49.75M35.97M30.70M25.64M
Selling and marketing
0000000000
Total operating expenses
586.88M456.05M440.35M415.05M338.03M284.53M214.02M161.7M137.95M109.98M
Operating income
372.69M229.55M249.21M224.81M157.13M90.13M65.10M28.66M8.36M16.54M
Other income (expenses), net
-182.13M58.66M7.60M38.54M3.3M1.20M734K99K167K319K
Income before tax
190.56M288.22M256.82M263.36M160.43M91.34M65.83M28.76M8.53M16.86M
Income tax expense
54.05M62.69M53.81M4.34M48.26M39.22M27.69M-84.92M1.17M1.84M
Net income
136.50M225.52M203.00M259.01M112.17M52.11M38.14M113.68M7.35M15.01M
Earnings per share
Basic EPS
354.495.772.541.210.92.80.190.38
Diluted EPS
2.984.944.435.612.451.170.852.650.180.37
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source